NEW YORK, Dec. 15 (GenomeWeb News) - With funding from the National Cancer Institute, the Burnham Institute for Medical Research will collaborate on a task force to define molecular signatures for prostate cancer, the not-for-profit research institution said today.
The consortium, led by University of California, Irvine will receive $9.5 million over the next five years.
In its tissue microarray analyses of 4,000 prostate tissue samples, the group will look for cancer markers that are indicative of the clinical behavior of prostate cancer cells, the institute said.
Other collaborating institutions include University of California, San Diego; Northwestern University; the Translation Genomic Institute of Phoenix; San Diego, Calif.-based Sidney Kimmel Cancer Center; and the Sun Health Research Institute.
The NCI funding is part of its Strategic Partnering to Evaluate Cancer Signatures Program. In addition to prostate cancer, NCI awarded funding for childhood leukemias, non-Hodgekin's lymphoma, lymphocytic leukemia, lung cancer, and breast cancer.